Outlook Therapeutics, Inc.
OTLK · NASDAQ
9/30/2025 | 9/30/2024 | 9/30/2023 | 9/30/2022 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $8,083,085 | $15 | $23 | $17 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $1,490,931 | $0 | $0 | $0 |
| Inventory | $3,338,404 | $0 | $0 | $0 |
| Other Curr. Assets | $4,476,549 | $12 | $8 | $10 |
| Total Curr. Assets | $17,388,969 | $27 | $31 | $28 |
| Property Plant & Equip (Net) | $225,508 | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $1 | $1 | $1 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $969,706 | $0 | $1 | $0 |
| Total NC Assets | $1,195,214 | $1 | $1 | $1 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $18,584,183 | $29 | $32 | $29 |
| Liabilities | – | – | – | – |
| Payables | $10,192,388 | $8 | $7 | $3 |
| Short-Term Debt | $58,897 | $29 | $36 | $11 |
| Tax Payable | $302,000 | $2 | $2 | $2 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $35,261,320 | $3 | $3 | $3 |
| Total Curr. Liab. | $45,814,605 | $43 | $47 | $20 |
| LT Debt | $188,801 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $4,768,438 | $59 | $0 | $0 |
| Total NC Liab. | $4,957,239 | $59 | $0 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $50,771,844 | $102 | $47 | $20 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $32,300,601 | $28,527,751 |
| Common Stock | $538,873 | $0 | $3 | $2 |
| Retained Earnings | -$605,709,763 | -$543 | -$468 | -$409 |
| AOCI | $0 | $0 | -$32,300,601 | $418 |
| Other Equity | $572,983,229 | $470 | $451 | -$28,527,336 |
| Total Equity | -$32,187,661 | -$73 | -$14 | $9 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $18,584,183 | $29 | $32 | $29 |
| Net Debt | -$7,835,387 | $15 | $12 | -$6 |